Presentation is loading. Please wait.

Presentation is loading. Please wait.

Time intervals and corresponding published guidelines in lung cancer care. Time intervals and corresponding published guidelines in lung cancer care. GP:

Published byRandolph Hardy Modified over 5 years ago

Similar presentations

Presentation on theme: "Time intervals and corresponding published guidelines in lung cancer care. Time intervals and corresponding published guidelines in lung cancer care. GP:"— Presentation transcript:

1 Time intervals and corresponding published guidelines in lung cancer care.
Time intervals and corresponding published guidelines in lung cancer care. GP: general practitioner; LCS: lung cancer specialist; IOM: Institute of Medicine; ACCP: American College of Chest Physicians; BTS: British Thoracic Society; NHS: National Health Service; SLCG: Swedish Lung Cancer Group; RAND: Research and Development; NOLCP: National Optimal Lung Cancer Pathway; SEHD: Scottish Executive Health Department; DLCG: Danish Lung Cancer Group; NSCLC: nonsmall cell lung cancer; SCLC: small cell lung cancer; SMAC: Standing Medical Advisory Committee. Ashanya Malalasekera et al. Eur Respir Rev 2018;27:180045 ©2018 by European Respiratory Society

Download ppt "Time intervals and corresponding published guidelines in lung cancer care. Time intervals and corresponding published guidelines in lung cancer care. GP:"

Similar presentations

Respiratory Care Understanding the Organizations that Serve Our Profession.

Respiratory Care Understanding the Organizations that Serve Our Profession.
Brief summary of the GRADE framework Holger Schünemann, MD, PhD Chair and Professor, Department of Clinical Epidemiology & Biostatistics Professor of Medicine.

Brief summary of the GRADE framework Holger Schünemann, MD, PhD Chair and Professor, Department of Clinical Epidemiology & Biostatistics Professor of Medicine.
Patients who had reported experiencing symptoms in the previous 7 days were asked during what times of the day the symptoms were most troublesome. a) Breathlessness,

Patients who had reported experiencing symptoms in the previous 7 days were asked during what times of the day the symptoms were most troublesome. a) Breathlessness,
Testing algorithm integrating diagnostic and predictive analysis in nonsmall cell lung cancer (NSCLC). Testing algorithm integrating diagnostic and predictive.

Testing algorithm integrating diagnostic and predictive analysis in nonsmall cell lung cancer (NSCLC). Testing algorithm integrating diagnostic and predictive.
The publication gap in years for the cumulative percent of cited research papers in the ESMO and the UK overall cancer clinical guidelines, with the difference.

The publication gap in years for the cumulative percent of cited research papers in the ESMO and the UK overall cancer clinical guidelines, with the difference.
Volume 143, Issue 5, Pages e437S-e454S (May 2013)

Volume 143, Issue 5, Pages e437S-e454S (May 2013)
The Integrated Performance Health Management and Coaching Model.

The Integrated Performance Health Management and Coaching Model.
Flowchart for calculating the relative risk (RR) for cancer X and lung cancer (LC). Flowchart for calculating the relative risk (RR) for cancer X and lung.

Flowchart for calculating the relative risk (RR) for cancer X and lung cancer (LC). Flowchart for calculating the relative risk (RR) for cancer X and lung.
Kaplan–Meier curves for a, b) progression-free survival (PFS) and c, d) overall survival (OS) in a, c) large-cell neuroendocrine carcinoma patients and.

Kaplan–Meier curves for a, b) progression-free survival (PFS) and c, d) overall survival (OS) in a, c) large-cell neuroendocrine carcinoma patients and.
Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation  Nicholas J. Gross, MD,

Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation  Nicholas J. Gross, MD,
Computed tomography simulation of medical thoracoscopy with rigid instruments (right thoracic cavity in left lateral position). Computed tomography simulation.

Computed tomography simulation of medical thoracoscopy with rigid instruments (right thoracic cavity in left lateral position). Computed tomography simulation.
Radiology assessment of pulmonary amyloidosis

Radiology assessment of pulmonary amyloidosis
Adil Ayub, MD, Sadiq S. Rehmani, MD, Adnan M

Adil Ayub, MD, Sadiq S. Rehmani, MD, Adnan M
Meta-analysis of randomised phase III clinical trials with ALK inhibitors in non-small cell lung cancer (NSCLC) showing similar benefit in male patients.

Meta-analysis of randomised phase III clinical trials with ALK inhibitors in non-small cell lung cancer (NSCLC) showing similar benefit in male patients.
Flowchart showing the requirement for starting, documenting and evaluating the effect on quality of life (QoL) of interdisciplinary best supportive care.

Flowchart showing the requirement for starting, documenting and evaluating the effect on quality of life (QoL) of interdisciplinary best supportive care.
Flow chart of the used methodology adapted from Moher et al

Flow chart of the used methodology adapted from Moher et al
High-resolution chest computed tomography images of a patient with lymphangioleiomyomatosis, showing round-shaped, thin-walled cysts distributed diffusely.

High-resolution chest computed tomography images of a patient with lymphangioleiomyomatosis, showing round-shaped, thin-walled cysts distributed diffusely.
Level of physical activity by Global Initiative for Obstructive Lung Disease (GOLD) stage, BODE (body mass index, FEV1 for airflow obstruction, dyspnoea,

Level of physical activity by Global Initiative for Obstructive Lung Disease (GOLD) stage, BODE (body mass index, FEV1 for airflow obstruction, dyspnoea,
a) Chest radiograph showing bilateral coarse interstitial shadowing

a) Chest radiograph showing bilateral coarse interstitial shadowing
Treatment algorithm for managing chronic thromboembolic pulmonary hypertension (CTEPH), from the European Society of Cardiology/European Respiratory Society.

Treatment algorithm for managing chronic thromboembolic pulmonary hypertension (CTEPH), from the European Society of Cardiology/European Respiratory Society.

Similar presentations

Ads by Google